wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35603660-5FB8333A-4F2F-4203-8A2B-E61038620A1F
Q35603660-5FB8333A-4F2F-4203-8A2B-E61038620A1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35603660-5FB8333A-4F2F-4203-8A2B-E61038620A1F
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.
P2860
Q35603660-5FB8333A-4F2F-4203-8A2B-E61038620A1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35603660-5FB8333A-4F2F-4203-8A2B-E61038620A1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bffef8b59ccfab75c265071c0bf8d2aeb9b28809
P2860
Overview of the latest treatments for castration-resistant prostate cancer.